Firetrail’s Absolute Fund exceeds $73.5m

The initial public offering of Firetrail Absolute Return Limited (FTA) has exceeded its minimum target of $73.5 million, with the deal remaining now open for firm bids above $73.5 million.

The listed investment company (LIC), which aimed to provide investors with access to an ‘alternative’ source of investment returns, uncorrelated to Australian and global share markets, is managed by Firetrail Investments Pty Limited, an affiliated fund manager of Pinnacle Investment Management.

The IPO intended to raise up $304.5 million by issuing 145,000,000 fully paid ordinary shares at an application price of $2.10 per share with the ability to receive oversubscriptions up to $378 million.

Related News:

The product capacity was constrained to $1 billion which included the FTA raise and the unlisted fund, the firm said.

The offer is expected to close on 19 October 2018.

FTA said it would employ the same investment strategy as the Firetrail Absolute Return Fund.

Prior to establishing Firetrail earlier this year, co-portfolio managers Patrick Hodgens and James Miller ran the Macquarie Pure Alpha Fund, a similar market-neutral investment strategy.

“The strong early demand for the strategy illustrates an increasing move by investors towards alternative investment products,” chair of Firetrail Absolute Return Limited Deirdre Wroth said.




Related Content

Pengana’s trust IPO exceeds $100 mil minimum

Pengana Capital Group (PCG) has announced that the proceeds from the initial public offering (IPO) for its Private Equity Trust have exceeded the mini...Read more

New Perpetual credit income trust

Perpetual has announced the opening of the initial public offering (IPO) for its new Credit Income Trust (PCI) which would typically offer exposure to...Read more

Plato triples special dividend

The board of Plato Income Maximiser (PL8), a listed investment company (LIC), has announced an increase in its special dividend to three cents per sha...Read more

Author

Comments

Add new comment